Results 71 to 80 of about 1,036,661 (382)
In August 2023, FDA approved Abrysvo for active immunization of pregnant individuals at 32 through 36 weeks gestational age to prevent lower respiratory tract disease (LRTD), including severe LRTD, caused by respiratory syncytial virus (RSV) in infants ...
Yugenia K. Hong-Nguyen+4 more
doaj +1 more source
Drug Recall Monitoring and Trend Analysis: A Multidimensional Study [PDF]
Background: Control of the quality of pharmaceutical and healthcare products in the market is mandatory to ensure the safety and efficacy of the delivered product to the final consumers. The United States Food and Drug Administration (FDA) is providing a
Mostafa E. Eissa
doaj +1 more source
Decision Analysis and FDA Drug Review: A Proposal for Shadow Advisory Committees [PDF]
The FDA seems to acknowledge that sometimes different standards of proof for assessing drug efficacy should be used. Dr. Mendeloff thus proposes a methodology that might illuminate the FDA\u27s decision-making and help better to assess its ...
Mendeloff, John M.
core +1 more source
Functional Data Analysis in Electronic Commerce Research
This paper describes opportunities and challenges of using functional data analysis (FDA) for the exploration and analysis of data originating from electronic commerce (eCommerce).
Jank, Wolfgang, Shmueli, Galit
core +2 more sources
EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche+8 more
wiley +1 more source
Valley of the unicorns: consumer genomics, venture capital and digital disruption
Drawing on the sociology of expectations and sociology of conventions, this paper explores issues of worth and value in the bioeconomy, and the promissory character of contemporary capitalism.
Stuart Hogarth
doaj +1 more source
Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. [PDF]
BackgroundPrevious studies of drug trials submitted to regulatory authorities have documented selective reporting of both entire trials and favorable results.
Bacchetti, Peter+2 more
core +3 more sources
Proteomic and phosphoproteomic analyses were performed on lung adenocarcinoma (LUAD) tumors with EGFR, KRAS, or EML4–ALK alterations and wild‐type cases. Distinct protein expression and phosphorylation patterns were identified, especially in EGFR‐mutated tumors. Key altered pathways included vesicle transport and RNA splicing.
Fanni Bugyi+12 more
wiley +1 more source
Whole-cell pertussis (wP) vaccines introduced in the 1940s led to a dramatic reduction of pertussis incidence and are still widely used in low- and middle-income countries (LMICs) worldwide.
Parul Kapil+7 more
doaj +1 more source
Nanotechnology-based cosmetics: regulation, claims, and cosmetovigilance [PDF]
The rapid expansion of the cosmetics industry has been accompanied by an increasing demand for innovative and customized products based on scientific base. One of the innovative products is a nanotechnology-based product.
Ajeng Ilillastria Rosalina+1 more
doaj +1 more source